Kohli, R. M., Walsh, C. T., & Burkart, M. D. (2002). Biomimetic synthesis and optimization of cyclic peptide antibiotics. Nature, 418(6898), 658–661.
more information
Spellberg, B., & Shlaes, D. (2014). Prioritized current unmet needs for antibacterial therapies. Clin Pharmacol Ther, 96(2), 151–153.
more information
Iorga, B., Herlem, D., Barre, E., & Guillou, C. (2006). Acetylcholine nicotinic receptors: finding the putative binding site of allosteric modulators using the “blind docking” approach. J Mol Model, 12(3), 366–372.
more information
Changeux, J. - P. (2013). The concept of allosteric interaction and its consequences for the chemistry of the brain. J Biol Chem, 288(38), 26969–26986.
more information
Bertrand, D., & Gopalakrishnan, M. (2007). Allosteric modulation of nicotinic acetylcholine receptors. Biochem Pharmacol, 74(8), 1155–1163.
more information
Arias, H. R. (2010). Positive and negative modulation of nicotinic receptors. Adv Protein Chem Struct Biol, 80, 153–203.
more information
Albuquerque, E. X., Pereira, E. F. R., Alkondon, M., & Rogers, S. W. (2009). Mammalian nicotinic acetylcholine receptors: from structure to function. Physiol Rev, 89(1), 73–120.
more information
Valles, A. S., Borroni, M. V., & Barrantes, F. J. (2014). Targeting brain alpha7 nicotinic acetylcholine receptors in Alzheimer's disease: rationale and current status. CNS Drugs, 28(11), 975–987.
more information
Martin, L. F., Kem, W. R., & Freedman, R. (2004). Alpha-7 nicotinic receptor agonists: potential new candidates for the treatment of schizophrenia. Psychopharmacology (Berl), 174(1), 54–64.
more information
Briggs, C. A., Gronlien, J. H., Curzon, P., Timmermann, D. B., Ween, H., Thorin-Hagene, K., et al. (2009). Role of channel activation in cognitive enhancement mediated by alpha7 nicotinic acetylcholine receptors. Br J Pharmacol, 158(6), 1486–1494.
more information